Article

Herbrand, Lena ; Hofmann, Wolf-Karsten ; Hofheinz, Ralf-Dieter ; Büttner, Sylvia ; Haag, Georg Martin ; Gencer, Deniz (2024) Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group. Oncology Research and Treatment, 47 (1-2). pp. 1-9. ISSN 2296-5270 (Druck-Ausg.); 2296-5262 (Online-Ausg.)

Hohmann, Laura ; Merx, Kirsten ; Weingärtner, Simone ; Schreiber, Annette ; Hetjens, Svetlana ; Hofmann, Wolf-Karsten ; Hofheinz, Ralf-Dieter ; Gencer, Deniz (2023) Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany. Oncology Research and Treatment, 46 (10). pp. 426-434. ISSN 2296-5270 (Druck-Ausg.; 2296-5262 (Online-Ausg.)

Prinzhorn, Wiltrud ; Stehle, Michael ; Kleiner, Helga ; Ruppenthal, Sabrina ; Müller, Martin C. ; Hofmann, Wolf-Karsten ; Fabarius, Alice ; Seifarth, Wolfgang (2016) c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia. Biomarker Research, 4 (5). pp. 1-9. ISSN 2050-7771

Kripp, Melanie ; Heußer, Anna-Lena ; Belle, Sebastian ; Gerhardt, Axel ; Merx, Kirsten ; Hofmann, Wolf-Karsten ; Hofheinz, Ralf-Dieter (2015) Does Physical Activity Improve Quality of Life in Cancer Patients Undergoing Chemotherapy? Oncology Research and Treatment, 38 (5). pp. 230-236. ISSN 2296-5270 (Druck-Ausg.), 2296-5262 (Online-Ausg.)

Nissen, Johanna C. ; Hummel, Margit ; Brade, Joachim ; Kruth, Jens ; Hofmann, Wolf-Karsten ; Buchheidt, Dieter ; Reinwald, Mark (2014) The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience. BMC Infectious Diseases, 14 (364). pp. 1-11. ISSN 1471-2334

Erben, Philipp ; Nowak, Daniel ; Sauer, Christian ; Ströbel, Philipp ; Hofmann, Wolf-Karsten ; Hofheinz, Ralf-Dieter ; Hohenberger, Peter ; Kasper, Bernd (2012) Molecular analysis of desmoid tumors with a high-density single-nucleotide polymorphism array identifies new molecular candidate lesions. Onkologie, 35 (11). pp. 684-688. ISSN 0378-584X